Literature DB >> 7356896

Assay of 6-thioguanine in human plasma.

T Dooley, J L Maddocks.   

Abstract

1. A fluorimetric method has been developed for measuring therapeutic concentrations of 6-thioguanine in human plasma. The drug was measured as an oxidized derivative, guanine 6-sulphonate. 2. 6-thioguanine was extracted from plasma by a novel procedure which isolated the drug from an interfering plasma components. This method involved the formation of the thioguanine phenyl mercury derivative in alkaline plasma and its extraction into toluene. The free drug was released by back-extraction into hydrochloric acid. 3. The assay is specific and shows a limit of sensitivity of 5 ng/ml. This was shown to be adequate for measuring plasma concentrations of 6-thioguanine after the administration of a 160 mg dose in a patient with leukaemia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356896      PMCID: PMC1429922          DOI: 10.1111/j.1365-2125.1980.tb04800.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Fluorometric assay of thioguanine.

Authors:  J M Finkel
Journal:  J Pharm Sci       Date:  1975-01       Impact factor: 3.534

2.  The solubilization of polycyclic aromatic hydrocarbons by purines.

Authors:  H Weil-Malherbe
Journal:  Biochem J       Date:  1946       Impact factor: 3.857

3.  Separation and detection of picomole quantities of azathioprine metabolites.

Authors:  J L Maddocks; G S Davidson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

4.  Studies on the biologic disposition of methotrimeprazine.

Authors:  A H Afifi; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1968-04       Impact factor: 4.030

5.  Pharmacology of 6-thioguanine in man.

Authors:  G A LePage; J P Whitecar
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

6.  Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

Authors:  H E Skipper; F M Schabel; L B Mellett; J A Montgomery; L J Wilkoff; H H Lloyd; R W Brockman
Journal:  Cancer Chemother Rep       Date:  1970-12

7.  Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.

Authors:  W R Bruce; B E Meeker; F A Valeriote
Journal:  J Natl Cancer Inst       Date:  1966-08       Impact factor: 13.506

8.  Specific and sensitive combined high-performance liquid chromatographic-flow fluorometric assay for intracellular 6-thioguanine nucleotides metabolites of 6-mercaptopurine and 6-thioguanine.

Authors:  D M Tidd; S Dedhar
Journal:  J Chromatogr       Date:  1978-03-01

9.  Assay of azathioprine, 6-mercaptopurine and a novel thiopurine metabolite in human plasma.

Authors:  J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

  9 in total
  2 in total

1.  New Nanomedicine Approaches Using Gold-thioguanine Nanoconjugates as Metallo-ligands.

Authors:  Lee Sleightholm; Ajit Zambre; Nripen Chanda; Zahra Afrasiabi; Kattesh Katti; Raghuraman Kannan
Journal:  Inorganica Chim Acta       Date:  2011-06-15       Impact factor: 2.545

2.  Quantitation of chemosensitivity in acute myelocytic leukaemia.

Authors:  M G Lihou; P J Smith
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.